07/29/2026
Today, we are proud to announce the recipients of the 2026 SCN8A Research Grants Program. Funded through a collaboration between the International SCN8A Alliance, SCN8A Brazil, SCN8A France, SCN8A Nederland, SCN8A Spain, SCN8A UK & Ireland, and The Cute Syndrome Foundation, the program is awarding two $50,000 research grants to support innovative projects with the potential to advance the understanding and treatment of SCN8A-related disorders.
Congratulations to the 2026 recipients:
David Kastner, MD, PhD
Instructor, Psychiatry, UCSF Weill Institute for Neurosciences
Project: Development and Behavioral Characterization of an SCN8A Loss-of-Function Rat Line
Dr. Kastner’s team will create the first SCN8A loss-of-function rat model, providing a critical new research tool to better understand loss-of-function variants and accelerate the development of future therapies.
Chris Makinson, PhD
Assistant Professor, Department of Neurology, Columbia University Irving Medical Center
Project: Precision Molecular Actuators to Identify and Correct Pathogenic SCN8A Channel Dysfunction
Dr. Makinson’s team will use human cellular models carrying SCN8A variants to test small peptide modulators designed to correct specific problems in channel activation and inactivation, which could provide building blocks for future precision therapies.
These projects represent what the SCN8A Research Grants Program was established to support: innovative science with the potential to advance our understanding of SCN8A biology, expand therapeutic possibilities, and move the field closer to more meaningful treatments. Together, we are building a stronger foundation for discovery and creating new momentum for the global SCN8A community.